Sylvain Fisson Genethon Biography Publications Institution JoVE Articles Sylvain Fisson has not added a biography. If you are Sylvain Fisson and would like to personalize this page please email our Author Liaison for assistance. Publications ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma Diagnosis Ophthalmology. Jul, 2016 | Pubmed ID: 26948307 Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T Cells Journal of Immunology (Baltimore, Md. : 1950). Mar, 2016 | Pubmed ID: 26826251 Mouse Models of Primary Central Nervous System Lymphomas: Tools for Basing Funding and Therapeutic Strategies Journal of Neuro-oncology. Jan, 2015 | Pubmed ID: 25300908 Immunization of Mice with Lentiviral Vectors Targeted to MHC Class II+ Cells is Due to Preferential Transduction of Dendritic Cells in Vivo PloS One. 2014 | Pubmed ID: 25058148 Herpesvirus Detection and Cytokine Levels (IL-10, IL-6, and IFN-γ) in Ocular Fluid from Tunisian Immunocompetent Patients with Uveitis Journal of Medical Virology. Dec, 2013 | Pubmed ID: 23960020 Preclinical Study of Ublituximab, a Glycoengineered Anti-human CD20 Antibody, in Murine Models of Primary Cerebral and Intraocular B-cell Lymphomas Investigative Ophthalmology & Visual Science. May, 2013 | Pubmed ID: 23611989 Lymphoma B-cell Responsiveness to CpG-DNA Depends on the Tumor Microenvironment Journal of Experimental & Clinical Cancer Research : CR. 2013 | Pubmed ID: 23561041 Cytokine Profile in Human Eyes: Contribution of a New Cytokine Combination for Differential Diagnosis Between Intraocular Lymphoma or Uveitis PloS One. 2013 | Pubmed ID: 23405064 Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models Frontiers in Immunology. 2012 | Pubmed ID: 22566974 Murine Models of B-cell Lymphomas: Promising Tools for Designing Cancer Therapies Advances in Hematology. 2012 | Pubmed ID: 22400032 Th17 Cells Are Involved in the Local Control of Tumor Progression in Primary Intraocular Lymphoma PloS One. 2011 | Pubmed ID: 21949734 The Immune Microenvironments of Lung and Intraocular Tumors Bulletin Du Cancer. Jun, 2011 | Pubmed ID: 21616749 Tumor Microenvironment is Multifaceted Cancer Metastasis Reviews. Mar, 2011 | Pubmed ID: 21271351 Immune Infiltration in Human Cancer: Prognostic Significance and Disease Control Current Topics in Microbiology and Immunology. 2011 | Pubmed ID: 20512556 The Future of Primary Intraocular Lymphoma (retinal Lymphoma) Ocular Immunology and Inflammation. Nov-Dec, 2009 | Pubmed ID: 20001255 Selective Expression of Inhibitory Fcgamma Receptor by Metastatic Melanoma Impairs Tumor Susceptibility to IgG-dependent Cellular Response International Journal of Cancer. Dec, 2008 | Pubmed ID: 18798552 Animal Models of Intraocular Lymphomas Ophthalmic Research. 2008 | Pubmed ID: 18421241 Expansion of CD4+CD25+ Regulatory T Cells by Intravenous Immunoglobulin: a Critical Factor in Controlling Experimental Autoimmune Encephalomyelitis Blood. Jan, 2008 | Pubmed ID: 17932250 Impaired Th1/tc1 Cytokine Production of Tumor-infiltrating Lymphocytes in a Model of Primary Intraocular B-cell Lymphoma Investigative Ophthalmology & Visual Science. Jul, 2007 | Pubmed ID: 17591892 Induction of Antigen-specific Tolerance by Intrathymic Injection of Lentiviral Vectors Blood. Nov, 2006 | Pubmed ID: 16809618 Regulatory T Cells Control Uveoretinitis Induced by Pathogenic Th1 Cells Reacting to a Specific Retinal Neoantigen Journal of Immunology (Baltimore, Md. : 1950). Jun, 2006 | Pubmed ID: 16751360 Therapeutic Potential of Self-antigen-specific CD4+ CD25+ Regulatory T Cells Selected in Vitro from a Polyclonal Repertoire European Journal of Immunology. Apr, 2006 | Pubmed ID: 16525991 Natural Regulatory T Cells Control the Development of Atherosclerosis in Mice Nature Medicine. Feb, 2006 | Pubmed ID: 16462800 Identification of New CNS-resident Macrophage Subpopulation Molecular Markers for the Discrimination with Murine Systemic Macrophages Journal of Neuroimmunology. Dec, 2005 | Pubmed ID: 16169092 Ex Vivo Selection of Recipient-type Alloantigen-specific CD4(+)CD25(+) Immunoregulatory T Cells for the Control of Graft-versus-host Disease After Allogeneic Hematopoietic Stem-cell Transplantation Transplantation. Jan, 2004 | Pubmed ID: 14726768 Recipient-type Specific CD4+CD25+ Regulatory T Cells Favor Immune Reconstitution and Control Graft-versus-host Disease While Maintaining Graft-versus-leukemia The Journal of Clinical Investigation. Dec, 2003 | Pubmed ID: 14660744 Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State The Journal of Experimental Medicine. Sep, 2003 | Pubmed ID: 12939344 निगरानी ट्यूमर प्रगति और उपचार के प्रभाव माउस लिंफोमा मॉडल में bioluminescence आधारित ट्यूमर मात्रा का ठहराव विधि Jeremie Cosette1,2,3, Rym Ben Abdelwahed2, Sabrina Donnou-Triffault1,4,5, Catherine Sautès-Fridman2, Patrice Flaud*3, Sylvain Fisson*1,4,5 1Genethon, 2Cordeliers Research Center, INSERM U872, 3Matter and Complex Systems Laboratory, Université Paris Diderot, 4INSERM U951, 5UMR_S951, Université d'Evry Val d'Essonne JoVE 53609 Medicine
निगरानी ट्यूमर प्रगति और उपचार के प्रभाव माउस लिंफोमा मॉडल में bioluminescence आधारित ट्यूमर मात्रा का ठहराव विधि Jeremie Cosette1,2,3, Rym Ben Abdelwahed2, Sabrina Donnou-Triffault1,4,5, Catherine Sautès-Fridman2, Patrice Flaud*3, Sylvain Fisson*1,4,5 1Genethon, 2Cordeliers Research Center, INSERM U872, 3Matter and Complex Systems Laboratory, Université Paris Diderot, 4INSERM U951, 5UMR_S951, Université d'Evry Val d'Essonne JoVE 53609 Medicine